Live Breaking News & Updates on Renovorx Inc|Page 7

Stay updated with breaking news from Renovorx inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

RenovoRx Files New International Patent for Novel Targeted Combination Drug-Delivery Oncology Therapy Platform

RenovoRx Holds a Strong Intellectual Property Portfolio with 9 Issued Patents for its Proprietary Trans-Arterial Micro-Perfusion Therapy Platform and Delivery System

New Patent Would Expand IP. ....

Shaun Bagai , Company Phase Iii Tiger Pa , Exchange Commission , Renovorx Inc , Securities Exchange , Data Monitoring Committee , Patent Cooperation Treaty , Trans Arterial Micro Perfusion , Locally Advanced Pancreatic Cancer , Overall Survival , Drug Evaluation , Securities Act , Securities Exchange Act , R Pac Phase ,

RenovoRx (RNXT) Appoints Michel Ducreux to its Board

RenovoRx (RNXT) Appoints Michel Ducreux to its Board
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

France General , Michel Ducreux , Shaun Bagai , Gustave Roussy , Company Scientific Advisory Board , University Of Paris Sud , European Organisation For Research , Renovorx Inc , Gastrointestinal Tract Cancer Group , Saclay University , Scientific Advisory Board , Gastrointestinal Oncology Unit , Gastrointestinal Oncology Tumor Board , Paris Saclay University , Paul Brousse Hospital , Medical Affairs Director , European Organisation , Gastrointestinal Group , French Federation , Anticancer Centers , European Journal ,

RenovoRx Expands Scientific Advisory Board with Appointment of Michel Ducreux, M.D., Ph.D.

RenovoRx, Inc. , a clinical-stage biopharmaceutical company developing targeted combination therapies, today announced the appointment of Michel Ducreux, M.D., Ph.D. to the Company’s Scientific. ....

France General , Shaun Bagai , Michel Ducreux , Gustave Roussy , Gastrointestinal Tract Cancer Group , European Organisation For Research , Exchange Commission , Securities Exchange , Company Nasdaq , Saclay University , Renovorx Inc , University Of Paris Sud , Company Scientific Advisory Board , Scientific Advisory Board , Gastrointestinal Oncology Unit , Gastrointestinal Oncology Tumor Board , Paris Saclay University , Paul Brousse Hospital , Medical Affairs Director , European Organisation , Gastrointestinal Group , French Federation , Anticancer Centers , European Journal , Trans Arterial Micro Perfusion , Drug Evaluation ,

Renovorx Appoints Michel Ducreux as Scientific Advisory Board

RenovoRx, Inc. announced the appointment of Michel Ducreux, M.D., Ph.D. to the Company?s Scientific Advisory Board . Dr. Ducreux is
the Head of the Gastrointestinal Oncology Unit and Gastrointestinal. ....

France General , Gustave Roussy , Michel Ducreux , European Organisation For Research , Gastrointestinal Tract Cancer Group , Renovorx Inc , University Of Paris Sud , Saclay University , Scientific Advisory Board , Gastrointestinal Oncology Unit , Gastrointestinal Oncology Tumor Board , Paris Saclay University , Paul Brousse Hospital , Medical Affairs Director , European Organisation , Gastrointestinal Group , French Federation , Anticancer Centers , European Journal , Professor Ducreux ,

Maxim Group Downgrades RenovoRx Inc. (RNXT) to Hold

Maxim Group Downgrades RenovoRx Inc. (RNXT) to Hold
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Jason Mccarthy , Renovorx Inc , Maxim Group ,